News and Comments

Ariad’s (ARIA) ridaforolimus Brings Hope To Advanced Endometrial Cancer Patients.

  Monday, November 22, 2010

Endometrial cancer is the most common cancer of the female reproductive system. Advanced cases have virtually no effective treatments. Surgery, alone or in combination with radiation, chemotherapy, and/or hormonal therapy are good as initial therapy. In advanced stages, however, surgery has no role to play and chemotherapy has limited, if any, benefit.  More...


Recent Postings


Archive


Tags

NANTKWEST (NK) Ariad (ARIA) ImmunoGen (IMGN) SYNTA (SNTA) KITE (KITE) Intrexon (XON) ACADIA (ACAD) GUARDIAN HEALTH Theravance Bio Pharma (TBPH) Micromet (MITI) Auspex (ASPX) TOKAI (TKAOI) VANDA (VNDA) Sequenom (SQNM) REGULUS (RGLS) Sanofi (SNY) Pluristem (PSTI) Zerenex KERYX (KERX) Dynavax (DVAX) Trastuzumab-DM1 Ionis (IONS) Regeneron (REGN) Global Cell Therapeutics (GBT) Exelixis (EXEL) C4 Therapeutics Revlimid (lenolidamide) Sanofi-Aventis (SAN) Ridaforolimus Elan (ELN) Vitae Pharmaceuticals (VTAE) Abbott Laboratories (ABT) Roche (ROCHE) Sangamo (SGMO) Endometrial Cancer Mirati Therapeutics (MRTX) INNOVIVA (INVA) RenenxBio (RGNX) GlaxoSmithKline (GSK) Benlysta (belimumab) Merck (MRK) Intermune (ITMN) Ziofpharm (ZIOP) Herceptin Velcade (bortezomib) Telaprevir galapagos (GLPG) ZALTRAP™ Alder Biopharmaceuticals (ALDR) Editas (EDIT) Genentech Anacor (ANAC) Seattle Genetics (SGEN) NEKTAR (NKTR)) Prosensa (RNA) CompuGen (CGEN) Illumina (ILMN) Sarepta (SRPT) Onyx (ONXX) Valeant Pharmaceuticals International (VRX) Cytokinetics (CYTK) Prolor Biotech (PBTH) Tysabri Dendreon (DNDN) OSI (OSIP) Inovio (INO) Multiple Myeloma Idenix (IDIX) Sanofi (SNA) Gilead (GILD) ARCA (ABIO) ADVENTRIX (ANX) HALOZYME (HALO) Anadys (ANDS) ABBVIE (ABBV) SUNESIS PHARMACEUTICALS (SNSS) Agenus (AGEN) Alnylam (ALNY) AGOS (ARGS) IDERA (IDRA) Incyte (INCY) Spike Therapeutics (ONCE) Agenus (AGEN AERIE PHARMACEUTICALS SERES THERAPEUTICS (MCRB) Biocryst (BCRX) Human Longevity (HLI) ARGOS (ARGS) PTC Therapeutics (PTCT) ISIS (ISIS) Aimmune Therapeutics (AIMT) Roche (RHHBY) Biogen Idec (BIIB) Xoma (XOMA) JUNO (JUNO) Intercept (ICPT) Vertex (VRTX) Bristol-Myers Squibb (BMY) Galena (GALE) Theravance (THRX) Array Pharmaceuticals (ARRY) Jazz Pharmaceuticals (JAZZ) BIOMARIN (BMRN) Human Genome Sciences (HGSI) Rapamune Amgen (AMGN)